Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes and lipid interfaces are fundamental structural and functional components of all living cells, primarily composed of a phospholipid bilayer interspersed with proteins, sterols, and carbohydrates (NIH, 2018; Chemical Society Reviews, 2009). These interfaces serve as the primary barrier between the intracellular and extracellular environments, facilitating essential processes such as signal transduction, ion homeostasis, and molecular transport (NIH, 2008; MDPI, 2022). In pharmacology, the lipid interface is a critical target for several classes of drugs, most notably antimicrobial and antifungal agents like polymyxins and polyenes (ACS, 2020; UCL, 2024). These drugs exploit differences in lipid composition between host and pathogen membranes to induce pore formation or membrane disruption, leading to cell death (ResearchGate, 2019; ACS, 2020). Beyond infectious diseases, the physical properties of the membrane—such as fluidity, curvature, and the presence of specialized microdomains like lipid rafts—are increasingly recognized as targets in cancer and neurodegeneration (NIH, 2016; ResearchGate, 2014). Altered lipid metabolism in these diseases affects protein-lipid interactions and cellular signaling, making the membrane a viable site for therapeutic intervention (MDPI, 2022; NIH, 2016). However, the therapeutic window for membrane-targeting drugs is often narrow due to the potential for off-target effects on host cell membranes (NIH, 2010; ACS, 2020). This lack of selectivity can lead to significant safety concerns, including nephrotoxicity, neurotoxicity, and hemolysis (ResearchGate, 2019; ACS, 2020). Despite these challenges, the membrane remains a robust target because it is difficult for pathogens to develop resistance against physical disruption of their structural integrity (NIH, 2010; ResearchGate, 2019).
Direct interaction with membrane lipids leading to pore formation, membrane thinning, altered fluidity, or disruption of the lipid bilayer integrity, ultimately causing cell lysis or loss of electrochemical gradients (ACS, 2020; ResearchGate, 2014).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes and lipid interfaces.